"It's not that SPL7013 is less effective against the Omicron strain but rather the Omicron strain's inability to replicate to the high levels seen with the other strains in previous antiviral experiments, which limited the maximum possible reduction to >99.6% in this experiment".
Thanks Sarge17, that clarifies it.
Would've been nice if that had've been included when the Omicron test results were announced.
Personally i wasn't all that concerned.
I remember something similar happened previously when Vireleze was tested against a particular Variant.
Then some months later it was tested against the NEXT variant and it was bask to 99.99% effective.
I have no doubt that it will continue to show similar results when future variants emerge, as they surely will.
TGA TAKE NOTE AND APPROVE VIRALEZE.
The longer you wait the worse it is going to look when the public realize that they are being denied this product.
- Forums
- ASX - By Stock
- SPL
- Ann: SPL7013 in VIRALEZE virucidal against Omicron
Ann: SPL7013 in VIRALEZE virucidal against Omicron, page-53
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.008(9.20%) |
Mkt cap ! $39.14M |
Open | High | Low | Value | Volume |
9.0¢ | 9.5¢ | 8.8¢ | $334.2K | 3.710M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50354 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 22908 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 760087 | 0.089 |
2 | 147200 | 0.087 |
3 | 118061 | 0.086 |
3 | 220000 | 0.085 |
1 | 100000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 22908 | 2 |
0.096 | 5000 | 1 |
0.099 | 6837 | 1 |
0.100 | 71848 | 3 |
0.105 | 370000 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online